Orban, C.; Abramovic, A.; Gmeiner, R.; Lener, S.; Demetz, M.; Thomé, C.
The Influence of Preoperative Anticoagulant and Antiplatelet Therapy on Rebleeding Rates in Patients Suffering from Spinal Metastatic Cancer: A Retrospective Cohort Study. Cancers 2024, 16, 2052.
https://doi.org/10.3390/cancers16112052
AMA Style
Orban C, Abramovic A, Gmeiner R, Lener S, Demetz M, Thomé C.
The Influence of Preoperative Anticoagulant and Antiplatelet Therapy on Rebleeding Rates in Patients Suffering from Spinal Metastatic Cancer: A Retrospective Cohort Study. Cancers. 2024; 16(11):2052.
https://doi.org/10.3390/cancers16112052
Chicago/Turabian Style
Orban, Christoph, Anto Abramovic, Raphael Gmeiner, Sara Lener, Matthias Demetz, and Claudius Thomé.
2024. "The Influence of Preoperative Anticoagulant and Antiplatelet Therapy on Rebleeding Rates in Patients Suffering from Spinal Metastatic Cancer: A Retrospective Cohort Study" Cancers 16, no. 11: 2052.
https://doi.org/10.3390/cancers16112052
APA Style
Orban, C., Abramovic, A., Gmeiner, R., Lener, S., Demetz, M., & Thomé, C.
(2024). The Influence of Preoperative Anticoagulant and Antiplatelet Therapy on Rebleeding Rates in Patients Suffering from Spinal Metastatic Cancer: A Retrospective Cohort Study. Cancers, 16(11), 2052.
https://doi.org/10.3390/cancers16112052